$47.31+129.55% · 3M
Moving avg
1W+3.98%
1M+64.50%
3M+129.55%
6M+139.91%
YTD+147.18%
1Y+279.70%
3Y+406.26%
5Y-34.86%
52-week range
$11.26100% of range$45.00
Company health
Value2/6
Growth6/6
Profitability3/6
Health5/6
Dividend0/6
Bull vs bear
Strengths
- Analyst consensus is "Buy"
- High return on equity (3281%)
- Revenue compounding 27% a year
- Net cash on the balance sheet
Risks
- Trades 11% above the average analyst target
- Currently unprofitable
- More volatile than the market (beta 2.4)
Key statistics
Valuation
Market cap
$2.45B
Enterprise value
$1.90B
P/E ratio (TTM)
20.31x
P/S ratio (TTM)
4.94x
EV/EBITDA
122.18x
Per share & returns
EPS (TTM)
$2.16
Dividend yield
0.00%
Beta (1Y)
2.43
30-day change
+64.50%
Trading
Volume (24h)
984.91K
Previous close
$47.23
Shares outstanding
51.73M
About CareDx, Inc
Sector
Healthcare
Industry
Medical - Diagnostics & Research
Exchange
NASDAQ
Symbol
CDNA
CareDx, Inc is a mid-cap healthcare company in the Medical - Diagnostics & Research industry. Its shares are listed on NASDAQ (United States) and trade under the ticker CDNA.
Frequently asked questions
What is CareDx, Inc's market cap?
CareDx, Inc (CDNA) has a market capitalization of $2.45B.
What is CareDx, Inc's P/E ratio?
CareDx, Inc trades at a price-to-earnings (P/E) ratio of 20.31.
What exchange does CDNA trade on?
CDNA trades on NASDAQ.
Appears in
Eli Lilly and CompanyLLY
$1,220.51+0.45%
$1.15T cap
Johnson & JohnsonJNJ
$260.86+0.41%
$628.65B cap
AbbVie Inc.ABBV
$248.66-0.57%
$439.33B cap
UnitedHealth Group IncorporatedUNH
$405.59+0.85%
$368.33B cap
Roche Holding AGSWX: ROP
CHF 365.50-0.92%
$357.31B cap
Merck & Co., Inc.MRK
$132.93+1.92%
$328.31B cap
Novartis AGSWX: NOVN
CHF 124.20-1.32%
$289.92B cap
AstraZeneca PLCLON: AZN
£117.02-1.20%
$244.81B cap